Sarcopenia Screening Allows Identifying High-Risk Patients for Allogenic Stem Cell Transplantation

Sarcopenia Screening Allows Identifying High-Risk Patients for Allogenic Stem Cell Transplantation

Allogenic stem cell transplantation (aSCT) is the only potentially curative treatment for high-risk hematological diseases. Despite advancements in supportive measures, aSCT outcome is still affected by considerable transplant-related mortality. We implemented a new sarcopenia assessment prior to aS...

Full description

Bibliographic Details
Main Authors: Johannes Kirsten, Verena Wais, Sebastian V.W. Schulz, Elisa Sala, Gunnar Treff, Donald Bunjes, Jürgen M. Steinacker
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
sarcopenia
hematology
risk stratification
aerobic capacity
stem cell transplantation
Online Access:https://www.mdpi.com/2072-6694/13/8/1771

Internet

https://www.mdpi.com/2072-6694/13/8/1771

Similar Items